Dr Helmut Schuehsler

Chairman & CEO at TVM Capital Healthcare

Speaker

Dr. Schuehsler serves as Chairman and CEO of TVM

Capital Healthcare in Dubai and Singapore. TVM

Capital Healthcare is a private equity investment

platform created in 2009 focused on investing in and

building transformational healthcare companies in

the fast-growing emerging economies of the Middle

East and Southeast Asia, including the expansion of

Western companies into these regions. TVM Capital

Healthcare closed its latest oversubscribed growth

capital fund with a focus on Saudi Arabian healthcare

transformation in the summer of 2024 at USD 254M

and intends to mobilize total capital of more than USD

500M for about 10 portfolio companies in sub-sectors

such as pharma, device, and diagnostics

manufacturing, as well as single specialty clinics such

as post-acute and chronic care, home health and

disease management, reproductive medicine,

oncology, cardiology and the rapidly growing field of

digital health solutions.

In the Middle East, Dr. Schuehsler served as chairman

or director of several healthcare growth companies

since 2010, both in the field of specialized clinics as

well as medical device manufacturing.

Since joining the original TVM Capital company

(Techno Venture Management GmbH) in 1990 in

Munich, Dr. Schuehsler has led the company through

several transitions of ownership and strategy and has

been the deal maker on more than 30 direct

investments in life science and healthcare companies

in Europe, the U.S., and the Middle East. During his

tenure with TVM Capital from 1990-2012, he led the

life science investment practice, raised more than

US$1.2bn in committed capital, oversaw more than

100 investments in the health industry by teams out

of Munich and Boston and had more than 50 IPOs and

30 M&A exit transactions in the portfolio. In this

position as Managing Partner, he developed TVM

Capital into the leading and largest life science

investor in Germany in the 1990s, led the

development of the firm into one of the leading pan-

European and transatlantic investors. TVM Capital

was for many years among the top ten investors in life

sciences on the East Coast.

Starting in 2007, he spearheaded the expansion of the

firm into the field of emerging market healthcare

private equity which was domiciled in Dubai in 2009

and expanded to Singapore in late 2020. Both

regional teams are currently fundraising for regional

healthcare growth capital funds.

In terms of industry representation, from 2003 to

2007, Dr. Schuehsler served as chairman of the

Professional Standards Committee of the European

Private Equity and Venture Capital Association (EVCA,

now “Invest Europe”), where he led a team of up to

10 finance, audit and legal specialists as well as

industry practitioners in the development or

improvement of PE/VC industry guidance documents

such as the Code of Conduct. Finally, in 2007 he was

elected chairman of EVCA for the usual one-year

term. In 2014-2017, he served on the Steering

Committee of the MENA Private Equity Association.

On the technology commercialization and financing

side, Dr. Schuehsler served as a member of the

Technology Advisory Committee to chancellor

Helmut Kohl in Germany, was a board member of

Max-Planck Innovation GmbH in Munich for more

than 10 years and was a member of the Selection

Committee for the Technology Pioneers program and

the Steering Committee of the Entrepreneurship and

Successful Growth Research Program of the World

Economic Forum for several years.